Clincosm LogoSign in Get a demo

hairy cell leukemia

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hairy Cell Leukemia Patients

Not yet recruiting
  • Hairy Cell Leukemia
    • (no location specified)
    May 5, 2023

    Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)

    Active, not recruiting
    • Hairy Cell Leukemia
    • Moxetumomab Pasudotox-tdfk
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

    Recruiting
    • Hairy Cell Leukemia
    • Hairy Cell Leukemia Variant
    • CD22CART cell infusion
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Patients Previously Treated WithMustang Bio CAR-T Cell

    Enrolling by invitation
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • +10 more
    • Prior MB-102 CAR-T cell investigational product.
    • Prior MB-106 CAR-T cell investigational product.
    • Duarte, California
    • +4 more
    Dec 8, 2022

    Moxetumomab Pasudotox-tdfk (LUMOXITI)

    Recruiting
    • Hairy Cell Leukemia
      • Pueblo, Colorado
      • +1 more
      Aug 17, 2022

      Hairy Cell Leukemia Trial in La Jolla (Low dose vemurafenib plus rituximab)

      Recruiting
      • Hairy Cell Leukemia
      • Low dose vemurafenib plus rituximab
      • La Jolla, California
        Scripps MD Anderson Cancer Center
      May 19, 2022

      CLL/SLL, Waldenstrom Macroglobulinemia, Follicular Lymphoma Trial in Cincinnati, Columbus, Salt Lake City (LP-168)

      Recruiting
      • CLL/SLL
      • +6 more
      • Cincinnati, Ohio
      • +2 more
      May 7, 2022

      Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)

      Active, not recruiting
      Has Results
      • Hairy Cell Leukemia
      • Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 13, 2022

      Hairy Cell Leukemia, Leukemia, Leukemia, Hairy Cell Trial in United States (Vemurafenib, Obinutuzumab)

      Active, not recruiting
      • Hairy Cell Leukemia
      • +2 more
      • New Haven, Connecticut
      • +8 more
      Feb 7, 2022

      B-cell Chronic Lymphoid Malignancies Markers

      Recruiting
      • Chronic Lymphocytic Leukemia
      • +5 more
        • Strasbourg, France
          Hematology Laboratory - Strasbourg University Hospitals
        Jul 2, 2021

        Anemia, B-Cell Prolymphocytic Leukemia, Grade 1 Follicular Lymphoma Trial in Portland (drug, other, biological)

        Completed
        • Anemia
        • +13 more
        • Portland, Oregon
          OHSU Knight Cancer Institute
        Apr 29, 2021

        Melanoma, Thyroid Cancer, Colorectal Cancer Trial in Scottsdale, Salt Lake City, Spokane (PLX8394)

        Terminated
        • Melanoma
        • +6 more
        • Scottsdale, Arizona
        • +2 more
        Oct 13, 2020

        Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Trial in Houston (drug, other, biological)

        Recruiting
        • Hairy Cell Leukemia
        • Recurrent Hairy Cell Leukemia
        • Houston, Texas
          M D Anderson Cancer Center
        Mar 20, 2020

        Hairy Cell Leukemia Trial in Poland, United States (Moxetumomab Pasudotox (CAT 8015), CAT 8015 (Moxetumomab Pasudotox))

        Completed
        Has Results
        • Hairy Cell Leukemia
        • Moxetumomab Pasudotox (CAT 8015)
        • CAT 8015 (Moxetumomab Pasudotox)
        • Stanford, California
        • +3 more
        Jan 2, 2019

        Collecting and Storing Malignant, Borderline Malignant

        Completed
        • Acute Undifferentiated Leukemia
        • +13 more
        • Cytology Specimen Collection Procedure
        • Birmingham, Alabama
        • +191 more
        Jul 17, 2018

        V600E Mutation in B-RAF Gene in Chronic Lymphoproliferative

        Completed
        • Hairy Cell Leukemia
        • Splenic Marginal Zone Lymphoma
          • (no location specified)
          Aug 10, 2017

          Hairy Cell Leukemia Trial run by the NCI (BL22 (CAT-3888))

          Terminated
          Has Results
          • Hairy Cell Leukemia
          • BL22 (CAT-3888)
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Oct 7, 2015

          Hairy Cell Leukemia Trial run by the NCI (Roferon-A)

          Completed
          • Hairy Cell Leukemia
          • Bethesda, Maryland
            National Cancer Institute (NCI)
          Mar 3, 2008

          Leukemia, Hairy Cell Leukemia, HCL Trial in Poland, United Kingdom, United States (Immunotoxin therapy, CAT-8015 Immunotoxin,

          Unknown status
          • Leukemia
          • +2 more
          • Immunotoxin therapy
          • +2 more
          • Stanford, California
          • +4 more
          Apr 16, 2007